Table 3.

Use and results of microbiological testing of extrapulmonary samples

	Pleural TB,* N = 9	TB meningitis,† N = 13	Abdominal TB,‡ N = 20	TB lymphadenitis,§ N = 3	TB pericarditis,‖ N = 2
GXP	3 (33%)	3 (23%)	1 (5%%)	0 (0%)	0 (0%)
GXP+	2/3 (67%)	0/3 (0%)	1/1 (100%)	0/0 (0%)	0/0 (0%)
Smear microscopy	2 (22%)	1 (8%)	0 (0%)	2 (67%)	0 (0%)
Smear+	0/2 (0%)	0/1 (0%)	0/0 (0%)	2/2 (100%)	0/0 (0%)
Mycobacterial culture	1 (11%)	1 (8%)	0 (0%)	1 (33%)	1 (50%)
Culture+	1/1 (100%)	1/1 (100%)	0/0 (0%)	1/1 (100%)	1/1 (100%)
Total extrapulmonary microbiological tests performed	5/9¶ (56%)	5/13 (38%)	1/20 (5%)	2/3# (67%)	1/2 (50%)
Total extrapulmonary microbiological tests+	3/5 (60%)	1/5 (20%)	1/1 (100%)	2/2 (100%)	1/1 (100%)

GXP = GeneXpert; TB = tuberculosis. Obtained for 47/58 TB patients with extrapulmonary disease manifestations (11/58 patients with extrapulmonary manifestations had miliary or spinal TB and no samples obtained).

^*Pleural fluid tested.

^†CSF = cerebrospinal fluid tested.

^‡Ascites tested.

^§Lymph node aspirate tested.

^‖Pericardial fluid tested.

^¶One pleural sample had both smear and culture performed.

^#One lymph node sample had both smear and culture performed.